ELX-02
EL-001
Phase 1 small_molecule terminated
Quick answer
ELX-02 for Genetic Diseases is a Phase 1 program (small_molecule) at Eloxx Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eloxx Pharmaceuticals
- Indication
- Genetic Diseases
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated